Generics

Mylan taps Bill Szablewski as head of capital markets for Viatris
Former Bristol Myers Squibb executive Bill Szablewski will serve as head of capital markets for Viatris, the company being created by the merger of Mylan and Pfizer's Upjohn.
Lannett launches authorized generic of Tirosint
Levothyroxine sodium capsules had a market value of roughly $111 million for the 12 months ended September 2020, according to IQVIA, although actual generic market values are expected to be lower.

FTC clears proposed combination of Mylan, Upjohn

The combination of Mylan and Pfizer's Upjohn business is expected to close on Nov. 16, at which time the combined company will be renamed Viatris.
FDA gives tentative nod to Zydus Cadila for generic Tradjenta

Zydus Cadila’s linagliptin tablets will be available in a dosage strength of 5 mg, pending the Food and Drug Administration's final approval.
Aurobindo sells Natrol to New Mountain Capital

Proceeds from Aurobindo's divestiture of Natrol will be used to reduce debt and develop other new strategic initiatives, according to the company.
Alembic obtains FDA nod for 2 generics

Tavaborole topical solution had a market value of roughly $82 million and fenofibrate capsules had a market value of $17 million, for the 12 months ended June 2020.
FDA gives Zydus Cadila tentative OK for generic Xeljanz

Zydus Cadila's generic Xeljanz XR tablets provide a once-daily treatment for adult patients with moderately to severely active ulcerative colitis.
Ascend Labs’ VanWinkle named Cardinal Health’s generic trade rep of the year

Schuyler VanWinkle has been recognized by Cardinal Health as Generic Trade Representative of the Year for the second time in three years.
Zydus Cadila receives FDA blessing for 2 generics

The FDA has granted approval for Zydus Cadila's generic Proventil, and generic Vesicare.
Dr. Reddy’s relaunches OTC generic famotidine tablets

The company is re-launching its famotidine tablets in 10- and 20-mg tablets, store-brand equivalents of original strength and maximum strength Pepcid AC.

Mylan taps Bill Szablewski as head of capital markets for Viatris

Lannett launches authorized generic of Tirosint

FTC clears proposed combination of Mylan, Upjohn

FDA gives tentative nod to Zydus Cadila for generic Tradjenta

Aurobindo sells Natrol to New Mountain Capital

Alembic obtains FDA nod for 2 generics

FDA gives Zydus Cadila tentative OK for generic Xeljanz

Ascend Labs’ VanWinkle named Cardinal Health’s generic trade rep of the year

Zydus Cadila receives FDA blessing for 2 generics

Dr. Reddy’s relaunches OTC generic famotidine tablets